MilliporeSigma awarded $136.7M US government contract for lateral flow membrane facility
MilliporeSigma, the US life science business of Merck KGaA, was awarded a $136.7 million contract from the US Department of Defense to construct a lateral flow membrane production facility in Sheboygan, Wisconsin, over three years.
Capacity
85 million tests per month
ProductsHi-Flow Plus lateral flow membrane
“With this agreement, MilliporeSigma will construct a state-of-the-art lateral flow membrane production facility that will give our in vitro diagnostic (IVD) manufacturing customers greater flexibility and security of supply of our Hi-Flow Plus lateral flow membranes.”biospace.com
- 4 sources
- biospace.comMilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin - BioSpaceHeather McKenzieDec 29, 2021
- apnews.comMilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin | AP NewsDec 29, 2021
- foxbusiness.comBiden admin touts $137M deal for COVID test strip factory the company says it will take 3 years to build | Fox BusinessBreck DumasDec 30, 2021
- thehill.comPentagon awards $136.7M contract for domestic production of material critical for rapid COVID-19 testsJoseph ChoiDec 30, 2021
Summarized from public sources; check the original articles before acting on it.
ENDATA